Anticoagulants oraux directs, fibrillation atriale et accidents vasculaires cérébraux

Hart, 1998, Prevention of stroke in patients with nonvalvular atrial fibrillation, Neurology, 51, 674, 10.1212/WNL.51.3.674 Gage, 2001, Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation, JAMA, 285, 2864, 10.1001/jama.285.22.2864 Camm, 2010, Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC), Eur Heart J, 31, 2369, 10.1093/eurheartj/ehq278 Pisters, 2010, A novel userfriendly score (HAS-BLED) to assess one-year risk of major bleeding in atrial fibrillation patients: the Euro Heart Survey, Chest, 10.1378/chest.10-0134 Hart, 2007, Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation, Ann Intern Med, 146, 857, 10.7326/0003-4819-146-12-200706190-00007 Mueller, 2014, The quality of oral anticoagulation in general practice in patients with atrial fibrillation, Eur J Intern Med, 25, 247, 10.1016/j.ejim.2013.12.013 Béjot, 2009, Changes in risk factors and preventive treatments by stroke subtypes over 20 years: a population-based study, J Neurol Sci, 287, 84, 10.1016/j.jns.2009.08.062 Agence française de sécurité sanitaire des produits de santé, 2012 Cabral, 2013, Pharmacology of the new target-specific oral anticoagulants, J Thromb Thrombolysis, 36, 133, 10.1007/s11239-013-0929-5 Connolly, 2009, Dabigatran versus warfarin in patients with atrial fibrillation, N Engl J Med, 361, 1139, 10.1056/NEJMoa0905561 Connolly, 2013, The long-term multicenter observational study of Dabigatran treatment in patients with atrial fibrillation (RELY-ABLE) study, Circulation, 128, 237, 10.1161/CIRCULATIONAHA.112.001139 Patel, 2011, Rivaroxaban versus warfarin in nonvalvular atrial fibrillation, N Engl J Med, 365, 883, 10.1056/NEJMoa1009638 Granger, 2011, Apixaban versus warfarin in patients with atrial fibrillation, N Engl J Med, 365, 981, 10.1056/NEJMoa1107039 Giugliano, 2013, Edoxaban versus warfarin in patients with atrial fibrillation, N Engl J Med, 369, 2093, 10.1056/NEJMoa1310907 Ruff, 2014, Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials, Lancet, 383, 955, 10.1016/S0140-6736(13)62343-0 Harrington, 2013, Cost-effectiveness of apixaban, dabigatran, rivaroxaban, and warfarin for stroke prevention in atrial fibrillation, Stroke, 44, 1676, 10.1161/STROKEAHA.111.000402 Van de Werf, 2012, A comparison of dabigatran etexilate with warfarin in patients with mechanical heart valves. The randomized, phase II study to evaluate the safety and pharmacokinetics of oral dabigatran etexilate in patients after heart valve replacement (RE-ALIGN), Am Heart J, 163, 931, 10.1016/j.ahj.2012.03.011 Camm, 2012, 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC guidelines for the management of atrial fibrillation–developed with the special contribution of the European Heart Rhythm Association, Eur Heart J, 33, 2719, 10.1093/eurheartj/ehs253 Hohnloser, 2012, Myocardial ischemic events in patients with atrial fibrillation treated with dabigatran or warfarin in the RE-LY (randomized Evaluation of Long-Term Anticoagulation Therapy) trial, Circulation, 125, 669, 10.1161/CIRCULATIONAHA.111.055970 Pernod, 2013, Management of major bleeding complications and emergency surgery in patients on long-term treatment with direct oral anticoagulants, thrombin or factor-Xa inhibitors. Proposals of the Working Group on Perioperative Haemostasis (GIHP), Ann Fr Anesth Reanim, 32, 691, 10.1016/j.annfar.2013.04.016 De Smedt, 2010, Intravenous thrombolysis with recombinant tissue plasminogen activator in a stroke patient treated with dabigatran, Cerebrovasc Dis, 30, 533, 10.1159/000319886 Casado Naranjo, 2011, Fatal intracerebral hemorrhage associated with administration of recombinant tissue plasminogen activator in a stroke patient on treatment with dabigatran, Cerebrovasc Dis, 32, 614, 10.1159/000334578 Matute, 2011, Thrombolysis treatment for acute ischemic stroke in a patient on treatment with dabigatran, Thromb Haemost, 106, 178, 10.1160/TH11-01-0042 Lee, 2012, Intravenous thrombolysis in a stroke patient taking dabigatran, J Stroke Cerebrovasc Dis, 21, e11 Marrone, 2012, Thrombolysis in an ischemic stroke patient on dabigatran anticoagulation: a case report, Cerebrovasc Dis, 34, 246, 10.1159/000342307 Pfeilschifter, 2012, Thrombolysis with recombinant tissue plasminogen activator under dabigatran anticoagulation in experimental stroke, Ann Neurol, 71, 624, 10.1002/ana.23558 Dempfle, 2011, Fibrinolytic treatment of acute ischemic stroke for patients on new oral anticoagulant drugs, Cerebrovasc Dis, 32, 616, 10.1159/000334579 Les préconisations de la SFNV: hémorragie intracérébrale sous anticoagulants oraux directs. Mai 2014, http://societe-francaise-neurovasculaire.fr/.